P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
US11919918B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2022 |
| Grant date | Mar 5, 2024 |
| Priority date | — |
| Expiry date | May 27, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5325
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drug for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.